Nitric oxide induces the apoptosis of human BCR-ABL-positive myeloid leukemia cells: Evidence for the chelation of intracellular iron

Leukemia

Volumn 16, Issue 4, 2002, Pages 708-715

  Ferry Dumazet, H ^a   Mamani Matsuda, M ^a   Dupouy, M ^a   Belloc, F ^a   Thiolat, D ^a   Marit, G ^a   Arock, M ^b   Reiffers, J ^a   Mossalayi, M D ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

BCR ABL; CML; Iron; Nitric oxide

Indexed keywords

1,2,3,4 OXATRIAZOLIUM 5 AMINO 3 (3 CHLORO 2 METHYLPHENYL) CHLORIDE; AMMONIUM SULFATE; ANTIMITOTIC AGENT; BCR ABL PROTEIN; CASPASE 3; CD34 ANTIGEN; CHELATING AGENT; DEFEROXAMINE MESYLATE; FERRIC CITRATE; FERRIC ION; FERROCYANIDE; GEA 5024; INTERLEUKIN 1; IRON; LEUPEPTIN; LINSIDOMINE; LIPOCORTIN 5; MOLSIDOMINE; NITRIC OXIDE; NITRITE; NITROPRUSSIDE SODIUM; PENICILLAMINE DERIVATIVE; PEPSTATIN; PHOSPHATIDYLSERINE; PHYTOHEMAGGLUTININ; POTASSIUM FERRICYANIDE; S NITROSO N ACETYL PENICILLAMINE; SAPONIN; SODIUM CYANIDE; STEM CELL FACTOR; UNCLASSIFIED DRUG;

APOPTOSIS; CELL ACTIVITY; CELL GROWTH; CELL PROLIFERATION; CHELATION; CHRONIC MYELOID LEUKEMIA; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LEUKOCYTE; MACROPHAGE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW;

EID: 85014196381     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402404     Document Type: Review

References (44)

1. Nitric oxide-cyclic GMP signal transduction system
2. Molecular mechanisms and therapeutic strategies related to nitric oxide
3. Nitric oxide and macrophage function
4. Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: A review
5. Nitric oxide modulation of human leukemia cell differentiation and gene expression
6. Growth arrest and terminal differentiation of leukemic myelomonocytic cells induced through ligation of surface CD23 antigen
7. Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha
8. Schedule and concentration-dependent induction of apoptosis in leukemia cells by nitric oxide
9. Mechanisms involved in the pro- and anti-apoptotic role of NO in human leukemia
10. Nitric oxide prevents oxidative damage produced by tert-butyl hydroperoxide in erythroleukemia cells via nitrosylation of heme and non-heme iron. Electron paramagnetic resonance evidence
11. Detection of inducible nitric oxide synthase (iNOS) mRNA by RT-PCR in ATL patients and HTLV-I infected cell lines: Clinical features and apoptosis by NOS inhibitor
12. Nitric oxide inhibits tumor necrosis factor-alpha-induced apoptosis by reducing the generation of ceramide
13. B-cell chronic lymphocytic leukemia cells express a functional inducible nitric oxide synthase displaying anti-apoptotic activity
14. Nitric oxide suppresses apoptosis via interrupting caspase activation and mitochondrial dysfunction in cultured hepatocytes
15. Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth
16. Iron-induced carcinogenesis: The role of redox regulation
17. Iron, asbestos, and carcinogenicity
18. Participation of iron and nitric oxide in the mutagenicity of asbestos in hgprt-, gpt+ Chinese hamster V79 cells
19. Studies of iron deposits, inducible nitric oxide synthase and nitrotyrosine in a rat model for esophageal adenocarcinoma
20. Generation of EPR-detectable nitrosyl-iron complexes in tumor target cells cocultured with activated macrophages
21. Induction of iron-derived EPR signals in murine cancers by nitric oxide. Evidence for multiple intracellular targets
22. The effect of redox-related species of nitrogen monoxide on transferrin and iron uptake and cellular proliferation of erythroleukemia (K562) cells
23. Inhibition of hemoglobin expression by heterologous production of nitric oxide synthase in the K562 erythroleukemic cell line
24. Flow cytometry study of human cyclin B1 and cyclin E expression in leukemic cell lines: Cell cycle kinetics and cell localization
25. Flow cytometry detection of caspase 3 activation in preapoptotic leukemic cells
26. Quantitative analysis
27. Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase
28. The iron component of sodium nitroprusside blocks NMDA-induced glutamate accumulation and intracellular Ca2+ elevation
29. Expression of a functional inducible nitric oxide synthase in hairy cell leukemia and ESKOL cell line
30. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation
31. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells
32. Biosynthesis of nitric oxide activates iron regulatory factor in macrophages
33. Sodium nitroprusside prevents chemical hypoxia-induced cell death through iron ions stimulating the activity of the Na+-Ca2+ exchanger in C6 glioma cells
34. Iron depletion: Possible cause of tumor cell cytotoxicity induced by activated macrophages
35. Iron chelators induce apoptosis in proliferating cells
36. Desferioxamine increases iron depletion and apoptosis induced by ara-C of human myeloid leukaemic cells
37. Interferon (IFN)-alpha activation of human blood mononuclear cells in vitro and in vivo for nitric oxide synthase (NOS) type 2 mRNA and protein expression: Possible relationship of induced NOS2 to the anti-hepatitis C IFN-alpha in vivo
38. Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy
39. Hepatic iron stainings in chronic hepatitis C patients with low HCV RNA levels: A predictive marker for IFN therapy
40. Cellular non-heme iron content is a determinant of nitric oxide-mediated apoptosis, necrosis, and caspase inhibition
41. Role of iron in tumor cell protection from the pro-apoptotic effect of nitric oxide
42. Leukocyte interferon-induced myeloid cytoreduction in chronic myelogenous leukemia
43. Development of clinical methods of iron deprivation for suppression of neoplastic and infectious diseases
44. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents III: The effect of the ligands on molecular targets involved in proliferation